Showing results (31-40 of 162) with videos related to
Sort By:
Pageof 17
The Journal of Clinical Investigation|December 15, 2022
Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular diseaseTraci T Goodchild, Zhen Li, David J LeferCirculation Research|October 26, 2018
Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular DiseaseZhen Li, David J Polhemus, David J LeferComprehensive Physiology|March 24, 2017
Protective Actions of H2S in Acute Myocardial Infarction and Heart FailureErminia Donnarumma, Rishi K Trivedi, David J LeferAmerican Journal of Physiology. Heart and Circulatory Physiology|December 25, 2003
HMG-CoA reductase inhibitor attenuates platelet adhesion in intestinal venules of hypercholesterolemic miceAnitaben Tailor, David J Lefer, D Neil GrangerCardiovascular Research|April 29, 2009
Protective ischaemia in patients: preconditioning and postconditioningAsger Granfeldt, David J Lefer, Jakob Vinten-JohansenAntioxidants & Redox Signaling|September 23, 2009
Novel insights into hydrogen sulfide--mediated cytoprotectionJohn W Calvert, William A Coetzee, David J LeferThe Journal of Nutrition|January 15, 2016
Garlic-Derived Organic Polysulfides and Myocardial ProtectionJessica M Bradley, Chelsea L Organ, David J LeferTrends in Cardiovascular Medicine|July 7, 2009
Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia/reperfusion injuryDavid J Lefer, Colin G Nichols, William A CoetzeeAmerican Journal of Physiology. Heart and Circulatory Physiology|August 23, 2005
Myocardial infarction and heart failure in the db/db diabetic mouseJames J M Greer, Derek P Ware, David J LeferAmerican Journal of Physiology. Heart and Circulatory Physiology|September 5, 2006
Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathwayJohn W Elrod, James J M Greer, David J LeferPageof 17